slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 22,231-22,260
Pages 1,249
Rows per page 30
Beat
22,231-22,260 of 37,461
10
Includes non-GAAP measures and specific definitions for capital ratios in the footer.Synchrony Financial | Results Presentation Deck | 17 slides · Synchrony
Conference presentation Investor relations Beat · Satisfaction1 hit
07
The slide presents interim Phase 1b data from a study by Maurer et al. (EAACI, 2022).Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a combination of a bulleted list for qualitative benefits and a table for quantitative selectivity data.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Product1 hit
09
The slide uses a staircase diagram to represent dose escalation and a crossover design for the food effect study.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
10
The chart displays multiple dose regimens (200mg QD, 200mg BID, 500mg QD FED, 400mg BID) with error bars representing standard deviation.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
11
MAD = Multiple Ascending Dose; SAE = Serious Adverse Event; AE = Adverse Event; ANC = Absolute Neutrophil Count; PBO = Placebo.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
12
The chart tracks neutrophil levels from Day 1 to Day 70/EOS, with an 'End of treatment' marker at Day 14.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
13
Includes a disclaimer about the reliability of cross-study comparisons.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
14
Includes two line charts with error bars representing mean +/- SD. LLOQ marked on the absolute chart.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a split-layout: left side describes the drug product, right side lists clinical trial status for Fibromyalgia, Long COVID, and PTSD.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Includes clinical trial status (RELIEF, RALLY, RESILIENT) and market demographics.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Clinical trial design slide for Tonix Pharmaceuticals.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Slide 10 of a corporate presentation deck.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide outlines a clinical trial protocol for TNX-102 SL in Long COVID patients.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes disclaimer about non-approval and patent status.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Slide 13 of a Tonix Pharmaceuticals presentation.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
Includes clinical trial status and mechanism of action highlights.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Slide provides a high-level summary of a pharmaceutical asset's profile and development roadmap.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Includes footnotes defining the metrics used in the charts.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
HFI = Held for Investment; C&I = Commercial & Industrial; PAA = Purchase Accounting Adjustment; CRE = Commercial Real Estate; PPP = Paycheck Protection Program.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide includes a footnote explaining the cumulative beta calculation.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Includes breakdown of Core net interest income vs Purchase accounting accretion (PAA) and Reported NIM vs Core NIM.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Includes a small data table at the bottom for 'Other income detail' and a stacked bar chart showing fee income ratio.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a stacked bar chart to show expense composition and overlay markers for efficiency ratios.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
The slide uses a consistent color palette and layout to compare credit performance metrics across time.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Includes preliminary regulatory capital information.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide maps business units to corporate functions and highlights three specific operational improvements.Unilever | Investor Event Presentation Deck | 29 slides · Unilever
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
08
Unilever branding present in bottom left corner.Unilever | Investor Event Presentation Deck | 29 slides · Unilever
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
09
USG = Underlying Sales Growth, UVG = Underlying Volume Growth, UPG = Underlying Price Growth.Unilever | Investor Event Presentation Deck | 29 slides · Unilever
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
Unilever | Investor Event Presentation Deck | 29 slidesUnilever | Investor Event Presentation Deck | 29 slides · Unilever
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit